Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why the immune system fails to mount an adaptive immune response to a COVID‐19 infection
Pedram Ahmadpoor, Lionel Rostaing
Transplant International (2020) Vol. 33, Iss. 7, pp. 824-825
Closed Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Víctor J. Costela‐Ruiz, Rebeca Illescas‐Montes, José Manuel Puerta-Puerta, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 54, pp. 62-75
Open Access | Times Cited: 1078
International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium
Gabriel A. Brat, Griffin M. Weber, Nils Gehlenborg, et al.
npj Digital Medicine (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 194
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
Iacopo Chiodini, Davide Gatti, Davide Soranna, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 150
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 132
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 103
Association of vitamin D status with COVID-19 and its severity
Jae Hyun Bae, Hun Jee Choe, Michael F. Holick, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 579-599
Open Access | Times Cited: 78
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
S. C. Verma, Danielle Twilley, Tenille Esmear, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 130
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
Corrado Pelaia, Caterina Tinello, Alessandro Vatrella, et al.
Therapeutic Advances in Respiratory Disease (2020) Vol. 14
Open Access | Times Cited: 126
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics
Helen A. Brough, Ömer Kalaycı, Anna Šedivá, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. 5, pp. 442-448
Open Access | Times Cited: 110
Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019
S. Ali Husain, Geoffrey K. Dube, Heather Morris, et al.
Clinical Journal of the American Society of Nephrology (2020) Vol. 15, Iss. 8, pp. 1174-1178
Open Access | Times Cited: 95
Age-related mitochondrial dysfunction as a key factor in COVID-19 disease
Daniel J.M. Fernández‐Ayala, Plácido Navas, Guillermo López‐Lluch
Experimental Gerontology (2020) Vol. 142, pp. 111147-111147
Open Access | Times Cited: 95
The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience
Peter S. Staats, Georgios F. Giannakópoulos, Justyna Blake, et al.
Neuromodulation Technology at the Neural Interface (2020) Vol. 23, Iss. 6, pp. 784-788
Open Access | Times Cited: 77
COVID-19 in elderly kidney transplant recipients
Marta Crespo, María José Pérez‐Sáez, Dolores Redondo‐Pachón, et al.
American Journal of Transplantation (2020) Vol. 20, Iss. 10, pp. 2883-2889
Open Access | Times Cited: 70
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
Giorgio Costagliola, Erika Spada, Rita Consolini
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 2, pp. 331-339
Open Access | Times Cited: 68
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 60
Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model
Tingxuan Gu, Simin Zhao, Guoguo Jin, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 59
Vitamin D regulation of the immune system and its implications for COVID-19: A mini review
Linda Bui, Zahra Zhu, Stephanie Hawkins, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 56
Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis
Huating Hu, Hudan Pan, Runze Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
Silvia Vivarelli, Luca Falzone, Francesco Torino, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 2, pp. 145-157
Open Access | Times Cited: 58
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3059-3059
Open Access | Times Cited: 54
Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge
Domenico Nuzzo, Sonya Vasto, Luca Scalisi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1947-1947
Open Access | Times Cited: 49
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)
José Alberto Choreño-Parra, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing
Xiyun Jin, Wenyang Zhou, Meng Luo, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 45
Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19
Stephanie S. Kulaga, Christopher W. T. Miller
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 520-530
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top